WebThe 4 analysts offering 12-month price forecasts for Curis Inc have a median target of 7.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +1,106.90%... WebApr 6, 2024 · Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid ...
Did you know?
WebApr 6, 2024 · See the latest Curis Inc stock price (NASDAQ:CRIS), related news, valuation, dividends and more to help you make your investing decisions. WebApr 12, 2024 · Moleculin Biotech - MBRX Stock Forecast, Price & News $0.96 +0.02 (+2.13%) (As of 03/31/2024 12:00 AM ET) Compare Today's Range $0.94 $0.96 50-Day Range $0.90 $1.30 52-Week Range $0.82 $2.05 Volume 31,859 shs Average Volume 96,116 shs Market Capitalization $27.48 million P/E Ratio N/A Dividend Yield N/A Price …
WebOct 22, 2012 · Curis is a small cap biotech stock with tremendous near term upside potential. In many analysts' opinions, the market has not yet realized the earnings potential and scope of the new drug Erivedge . WebApr 6, 2024 · A high-level overview of Curis, Inc. (CRIS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
WebApr 5, 2024 · LEXINGTON, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates ... WebApr 7, 2024 · As of April 06, 2024, Curis, Inc. had a $58.0 million market capitalization, putting it in the 28th percentile of companies in the Biotechnology & Medical Research …
WebApr 3, 2024 · Curis to Release Fourth Quarter 2024 Financial Results and Hold Conference Call on March 9, 2024. LEXINGTON, Mass. , March 2, 2024 /PRNewswire/ -- Curis, Inc. …
WebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … chipotle investor relationsWebDec 15, 2024 · Curis is focused on the discovery and development of drug candidates for the treatment of cancer. The stock currently trades right around $4.50 a share and sports an approximate market... chipotle in salt lake cityWeb1) In April 2024, the U.S. Food and Drug Administration (“FDA”) placed the TakeAim Leukemia study on partial clinical hold. In August 2024, the FDA notified Curis that it may resume enrollment in the monotherapy dose finding phase of the study. The partial hold remains in place for the combination therapy and expansion phases of the study. grant\\u0027s real first nameWebApr 6, 2024 · Curis ( NASDAQ: CRIS) said a new employee will be granted stock options to buy 135.45K common shares of the company. The inducement grant has an exercise … chipotle in southbury ctWebJan 24, 2024 · LEXINGTON, Mass., Jan. 24, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today ... grant\u0027s scotch whiskyWebProvide the latest Biotechnology (BK2069) market data, including prices, cycle charts, basic information and real-time news information, financial analysis, company introduction, dividends and dividend information, you can also use Moomoo to open an account to trade Biotechnology stocks，we will provide investors with reference decision data. chipotle in peachtree city gaWebApr 6, 2024 · LEXINGTON, Mass., April 5, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today ... chipotle in springfield pa